Filter by Category: SENTRY Surveillance

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report.

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report. by Castanheira M, Sader HS, Jones RN, Debbia Eugenio, Picao RC and Gales AC published in Microb. Drug Resis. 2007; 13 (2): 130-134

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY Antimicrobial Surveillance Program.

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY Antimicrobial Surveillance Program. by Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58: 163-170

Potency and spectrum of garenoxacin tested against an international collection of skin and skin tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004).

Potency and spectrum of garenoxacin tested against an international collection of skin and skin tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58 (1): 19-26

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test reslt for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program.

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test reslt for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. by Bell JM, Chitsaz M, Turnidge JD, Barton M, walters LJ and Jones RN published in J. Clin. Microbiol. 2007; 45 (5): 1478-1482

Activity of linezolid against 3,251 strains of uncommonly isolated Gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program.

Activity of linezolid against 3,251 strains of uncommonly isolated Gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Stilwell MG, Hogan PA and Sheehan DJ published in Antimicrob. Agents Chemother. 2007; 51 (4): 1491-1493

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 7-13

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Jones RN, Sader HS, Fritsche TR and Pottumarthy S published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 109-116

Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). by Deshpande LM, Jones RN, Fritsche TR and Sader HS published in Int. J. Antimicrob. Agents 2006; 28 (6): 578-581

Characterization of fluoroquinolone-resistant β-haemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997-2004).

Characterization of fluoroquinolone-resistant β-haemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 119-127

Activity of gatifloxacin tested against isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).

Activity of gatifloxacin tested against isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003). by Fedler KA, Jones RN, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 157-164